Genotype-guided switch from ravulizumab to satralizumab in aquaporin-4–IgG–positive neuromyelitis optica spectrum disorder: a case of C5 polymorphism-associated ravulizumab resistance

View at publisher Summarise with VIRAT
Authors: Hiroyuki Naito, Takamichi Sugimoto, Yu Yamazaki, Hirofumi Maruyama
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Multiple Sclerosis Research Studies Complement system in diseases Peripheral Neuropathies and Disorders

Publication details

Journal / source
Neurological Sciences
Volume
47
Issue
4
Publication date
28 March 2026
Language
EN